Jamie E Mells1, Ping P Fu2, Pradeep Kumar2, Tekla Smith2, Saul J Karpen1, Frank A Anania3. 1. Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, 30322, USA. 2. Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA. 3. Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA. Electronic address: fanania@emory.edu.
Abstract
UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome (MetS). Up to a third of NAFLD subjects are at risk for developing nonalcoholic steatohepatitis (NASH). Many rodent models fail to replicate both MetS and NASH. The purpose of this study was to develop a reliable mouse model of NASH and MetS using a diet containing cholesterol, saturated fat and carbohydrate that is reflective of Western diets of North Americans. EXPERIMENTAL DESIGN: We used adult male C57BL/6 J 4- to 5-week-old mice and administered a solid diet containing 0.2% cholesterol, 45% of its calories from fat, with 30% of the fat in the form of partially hydrogenated vegetable oil. We also provided carbohydrate largely as high-fructose corn syrup equivalent in water. In a separate cohort, we gave the identical diet in the absence of cholesterol. Glucose and insulin tolerance testing was conducted throughout the feeding period. The feeding was conducted for 16 weeks, and the mice were sacrificed for histological analysis, markers of MetS, liver inflammation, circulating lipids, as well as liver staining for fibrosis and alpha smooth muscle actin (α-SMA). RESULTS: We found that cholesterol significantly increased serum leptin, interleukin-6, liver weight and liver weight/body weight ratio, fibrosis and liver α-SMA. CONCLUSIONS: Mice administered a diet accurately reflecting patterns associated with humans afflicted with MetS can reliably replicate features of MetS, NASH and significant liver fibrosis. The model we describe significantly reduces the time by several months for development of stage 3 hepatic fibrosis.
UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome (MetS). Up to a third of NAFLD subjects are at risk for developing nonalcoholic steatohepatitis (NASH). Many rodent models fail to replicate both MetS and NASH. The purpose of this study was to develop a reliable mouse model of NASH and MetS using a diet containing cholesterol, saturated fat and carbohydrate that is reflective of Western diets of North Americans. EXPERIMENTAL DESIGN: We used adult male C57BL/6 J 4- to 5-week-old mice and administered a solid diet containing 0.2% cholesterol, 45% of its calories from fat, with 30% of the fat in the form of partially hydrogenated vegetable oil. We also provided carbohydrate largely as high-fructosecorn syrup equivalent in water. In a separate cohort, we gave the identical diet in the absence of cholesterol. Glucose and insulin tolerance testing was conducted throughout the feeding period. The feeding was conducted for 16 weeks, and the mice were sacrificed for histological analysis, markers of MetS, liver inflammation, circulating lipids, as well as liver staining for fibrosis and alpha smooth muscle actin (α-SMA). RESULTS: We found that cholesterol significantly increased serum leptin, interleukin-6, liver weight and liver weight/body weight ratio, fibrosis and liver α-SMA. CONCLUSIONS:Mice administered a diet accurately reflecting patterns associated with humans afflicted with MetS can reliably replicate features of MetS, NASH and significant liver fibrosis. The model we describe significantly reduces the time by several months for development of stage 3 hepatic fibrosis.
Authors: Karen L Teff; Sharon S Elliott; Matthias Tschöp; Timothy J Kieffer; Daniel Rader; Mark Heiman; Raymond R Townsend; Nancy L Keim; David D'Alessio; Peter J Havel Journal: J Clin Endocrinol Metab Date: 2004-06 Impact factor: 5.958
Authors: Núria Roglans; Laia Vilà; Mireia Farré; Marta Alegret; Rosa María Sánchez; Manuel Vázquez-Carrera; Juan Carlos Laguna Journal: Hepatology Date: 2007-03 Impact factor: 17.425
Authors: David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal Journal: Hepatology Date: 2005-06 Impact factor: 17.425
Authors: R S Surwit; S Wang; A E Petro; D Sanchis; S Raimbault; D Ricquier; S Collins Journal: Proc Natl Acad Sci U S A Date: 1998-03-31 Impact factor: 11.205
Authors: Tim C M A Schreuder; Bart J Verwer; Carin M J van Nieuwkerk; Chris J J Mulder Journal: World J Gastroenterol Date: 2008-04-28 Impact factor: 5.742
Authors: Xiaosen Ouyang; Pietro Cirillo; Yuri Sautin; Shannon McCall; James L Bruchette; Anna Mae Diehl; Richard J Johnson; Manal F Abdelmalek Journal: J Hepatol Date: 2008-03-10 Impact factor: 25.083
Authors: Ann E Petro; Juliann Cotter; Dale A Cooper; John C Peters; Sarah J Surwit; Richard S Surwit Journal: Metabolism Date: 2004-04 Impact factor: 8.694
Authors: Melissa A Linden; Ryan D Sheldon; Grace M Meers; Laura C Ortinau; E Matthew Morris; Frank W Booth; Jill A Kanaley; Victoria J Vieira-Potter; James R Sowers; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector Journal: J Physiol Date: 2016-05-27 Impact factor: 5.182
Authors: Olga Y Gasheva; Irina Tsoy Nizamutdinova; Laura Hargrove; Cassidy Gobbell; Maria Troyanova-Wood; Sally F Alpini; Sarit Pal; Christina Du; Angie R Hitt; Vlad V Yakovlev; M Karen Newell-Rogers; David C Zawieja; Cynthia J Meininger; Gianfranco D Alpini; Heather Francis; Anatoliy A Gashev Journal: Am J Physiol Gastrointest Liver Physiol Date: 2018-11-26 Impact factor: 4.052
Authors: Andrew A Pierce; Caroline C Duwaerts; Russell K Soon; Kevin Siao; James P Grenert; Mark Fitch; Marc K Hellerstein; Carine Beysen; Scott M Turner; Jacquelyn J Maher Journal: J Nutr Biochem Date: 2015-11-17 Impact factor: 6.048
Authors: Kristen Stephenson; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Gianfranco Alpini; Heather Francis Journal: Gene Expr Date: 2017-11-02
Authors: Anuradha Rao; Astrid Kosters; Jamie E Mells; Wujuan Zhang; Kenneth D R Setchell; Angelica M Amanso; Grace M Wynn; Tianlei Xu; Brad T Keller; Hong Yin; Sophia Banton; Dean P Jones; Hao Wu; Paul A Dawson; Saul J Karpen Journal: Sci Transl Med Date: 2016-09-21 Impact factor: 17.956
Authors: Miguel Vázquez-Velasco; Laura González-Torres; Patricia López-Gasco; Sara Bastida; Juana Benedí; María José González-Muñoz; Francisco J Sánchez-Muniz Journal: J Physiol Biochem Date: 2015-08-04 Impact factor: 4.158